GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (LTS:0A5V) » Definitions » Cyclically Adjusted FCF per Share

Viatris (LTS:0A5V) Cyclically Adjusted FCF per Share : $2.42 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Viatris Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Viatris's adjusted free cash flow per share for the three months ended in Mar. 2024 was $0.466. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $2.42 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Viatris was 25.10% per year. The lowest was -1.90% per year. And the median was 10.60% per year.

As of today (2024-06-10), Viatris's current stock price is $10.363. Viatris's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $2.42. Viatris's Cyclically Adjusted Price-to-FCF of today is 4.28.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Viatris was 58.96. The lowest was 3.58. And the median was 16.82.


Viatris Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Viatris's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris Cyclically Adjusted FCF per Share Chart

Viatris Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 1.59 2.18 2.32 2.36

Viatris Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.44 2.44 2.47 2.36 2.42

Competitive Comparison of Viatris's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viatris's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viatris's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Viatris's Cyclically Adjusted Price-to-FCF falls into.



Viatris Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Viatris's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.466/131.7762*131.7762
=0.466

Current CPI (Mar. 2024) = 131.7762.

Viatris Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.232 100.560 0.304
201409 0.138 100.428 0.181
201412 0.139 99.070 0.185
201503 0.467 99.621 0.618
201506 -0.100 100.684 -0.131
201509 1.101 100.392 1.445
201512 0.820 99.792 1.083
201603 -0.151 100.470 -0.198
201606 0.536 101.688 0.695
201609 2.036 101.861 2.634
201612 0.065 101.863 0.084
201703 0.590 102.862 0.756
201706 0.216 103.349 0.275
201709 0.785 104.136 0.993
201712 0.587 104.011 0.744
201803 0.481 105.290 0.602
201806 0.219 106.317 0.271
201809 1.149 106.507 1.422
201812 0.370 105.998 0.460
201903 -0.210 107.251 -0.258
201906 0.991 108.070 1.208
201909 0.830 108.329 1.010
201912 1.091 108.420 1.326
202003 0.349 108.902 0.422
202006 0.630 108.767 0.763
202009 0.900 109.815 1.080
202012 -0.493 109.897 -0.591
202103 0.659 111.754 0.777
202106 0.378 114.631 0.435
202109 0.786 115.734 0.895
202112 0.249 117.630 0.279
202203 0.879 121.301 0.955
202206 0.586 125.017 0.618
202209 0.618 125.227 0.650
202212 -0.019 125.222 -0.020
202303 0.737 127.348 0.763
202306 0.354 128.729 0.362
202309 0.606 129.860 0.615
202312 0.230 129.419 0.234
202403 0.466 131.776 0.466

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Viatris  (LTS:0A5V) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Viatris's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=10.363/2.42
=4.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Viatris was 58.96. The lowest was 3.58. And the median was 16.82.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Viatris Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Viatris's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Viatris (LTS:0A5V) Business Description

Industry
Address
1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Viatris (LTS:0A5V) Headlines

No Headlines